Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1164
mi
from
Huntington Beach, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1164
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1178
mi
from
Lomita, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1178
mi
from
Lomita, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1172
mi
from
Long Beach, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1172
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1168
mi
from
Los Angeles, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1168
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1133
mi
from
Norco, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1133
mi
from
Norco, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1173
mi
from
North Hollywood, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1173
mi
from
North Hollywood, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1163
mi
from
Norwalk, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1163
mi
from
Norwalk, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1216
mi
from
Oxnard, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1216
mi
from
Oxnard, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Palos Verdes, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Palos Verdes, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1167
mi
from
Paramount, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1167
mi
from
Paramount, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1119
mi
from
Rialto, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1119
mi
from
Rialto, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1142
mi
from
San Diego, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1142
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1159
mi
from
San Marino, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1159
mi
from
San Marino, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1315
mi
from
San Ramon, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1315
mi
from
San Ramon, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1276
mi
from
Stockton, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1276
mi
from
Stockton, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1135
mi
from
Upland, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1135
mi
from
Upland, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1151
mi
from
West Covina, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1151
mi
from
West Covina, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1162
mi
from
Westminster, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1162
mi
from
Westminster, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
400
mi
from
Centennial, CO
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
400
mi
from
Centennial, CO
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
409
mi
from
Denver, CO
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
409
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
412
mi
from
Northglenn, CO
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
412
mi
from
Northglenn, CO
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1291
mi
from
Boynton Beach, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1291
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1100
mi
from
Clearwater, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1100
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1311
mi
from
Doral, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1311
mi
from
Doral, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1307
mi
from
Fort Lauderdale, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1307
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1206
mi
from
Fort Myers, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1206
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1049
mi
from
Gainesville, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1049
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1313
mi
from
Hialeah, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1313
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1055
mi
from
Jacksonville, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1055
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1149
mi
from
Kissimmee, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1149
mi
from
Kissimmee, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1288
mi
from
Lake Worth, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1288
mi
from
Lake Worth, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1302
mi
from
Lauderdale Lakes, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1302
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1322
mi
from
Miami, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1322
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1141
mi
from
Orlando, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1141
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1309
mi
from
Pembroke Pines, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1309
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1117
mi
from
Tampa, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1117
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1284
mi
from
West Palm Beach, FL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1284
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
811
mi
from
Columbus, GA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
811
mi
from
Columbus, GA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
805
mi
from
Decatur, GA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
805
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
796
mi
from
Sandy Springs, GA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
796
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
599
mi
from
Wauconda, IL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
599
mi
from
Wauconda, IL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
630
mi
from
Avon, IN
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
630
mi
from
Avon, IN
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
559
mi
from
Evansville, IN
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
559
mi
from
Evansville, IN
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
675
mi
from
Mishawaka, IN
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
675
mi
from
Mishawaka, IN
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
26
mi
from
Wichita, KA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
26
mi
from
Wichita, KA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
582
mi
from
Lake Charles, LA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
582
mi
from
Lake Charles, LA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
693
mi
from
Metairie, LA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
693
mi
from
Metairie, LA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
697
mi
from
New Orleans, LA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
697
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1129
mi
from
Oxon Hill, MD
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1129
mi
from
Oxon Hill, MD
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
1405
mi
from
Worcester, MA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
1405
mi
from
Worcester, MA
Click here to add this to my saved trials